NSE: SHARDACROP | BSE: 538666

Strong Performer, Under Radar

Download real time

824.10 -4.90 (-0.59%)

30.22% Fall from 52W High

110.9K NSE+BSE Volume

NSE 16 Jan, 2026 3:31 PM (IST)

7,435.1

Market Cap

High in industry

Beta 1Year

Very High Volatility

Sharda Cropchem Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SHARDACROP, BSE:538666 Sharda Cropchem Ltd.

Search Inside the pdf :

Sharda Cropchem Ltd.

05 Dec 2025

824.10

-0.59%

Factory-to-Farmer

buy: Sharda Cropchem Ltd.

FundsIndia

Edge: High-entry-barrier regulatory portfolio + scalable global network

Sharda Cropchem Ltd. has an average target of 1159.67 from 3 brokers.

Sharda Cropchem Ltd.

04 Nov 2025

824.10

-0.59%

Inventory normalization across distribution channels support outlook

Buy: Sharda Cropchem Ltd.

Target

Khambatta Securities

SCL reported a robust performance in 2Q FY26, driven by strong volume growth and margin expansion. The Company remains optimistic about a gradual recovery in the global agrochemical market, noting that inventories have normalized across distribution channels.

Sharda Cropchem Ltd. is trading above its 200 day SMA of 809.7

Sharda Cropchem Ltd.

01 Nov 2025

824.10

-0.59%

Yet another solid quarter; momentum to persist; retaining a Buy

Buy: Sharda Cropchem Ltd.

Anand Rathi

Healthy, 35% y/y, volume growth and market-share gains in its key regions drove Sharda Cropchem’s Q2 results. Growth improved on better demand particularly in NAFTA and Europe coupled with near complete de-stocking across major regions.

Sharda Cropchem Ltd. has an average target of 1159.67 from 3 brokers.

Sharda Cropchem Ltd.

21 Aug 2025

824.10

-0.59%

Global agrochemical recovery fuels positive outlook

Buy: Sharda Cropchem Ltd.

Recommendation Target

Khambatta Securities

Sharda Cropchem Limited (SCL) reported a 25% y-o-y increase in total revenue for 1Q FY26, reaching Rs 984.8 crore.

Sharda Cropchem Ltd. has an average target of 1159.67 from 3 brokers.

Sharda Cropchem Ltd.

28 Jul 2025

824.10

-0.59%

Solid start to FY26; momentum to continue; retaining a Buy

Buy: Sharda Cropchem Ltd.

Target

Anand Rathi

Healthy, 13% y/y, volume growth and market-share gains in its key regions drove Sharda Cropchem’s Q1 results. Growth improved on the back of better demand scenario particularly in Europe and a near complete destocking across major regions.

Sharda Cropchem Ltd. is trading below its 30 day SMA of 865.8

Sharda Cropchem Ltd.

03 Jun 2025

824.10

-0.59%

Price recovery to fuel revenue growth

Hold: Sharda Cropchem Ltd.

Recommendation Target

Khambatta Securities

Sharda Cropchem Limited (SCL) reported solid growth in 4Q FY25 as revenues increased by 39.4% y-o-y to Rs 1,828.5 crore. This robust quarterly growth was mirrored by a strong overall top-line performance for the entirety of FY25.

Sharda Cropchem Ltd. is trading above its 200 day SMA of 809.7

Sharda Cropchem Ltd.

05 Mar 2025

824.10

-0.59%

Growth momentum to sustain; maintaining a Buy

Buy: Sharda Cropchem Ltd.

Anand Rathi

We recently met Sharda Cropchem’s Chairman and MD, Mr R V Bubna to gauge the business outlook. Management is confident of achieving double-digit revenue growth (guidance raised 26% y/y post Q3 results vs. 15-20% earlier) in FY25, particularly due to volumes and penetration into new markets.

Sharda Cropchem Ltd. is trading below its 30 day SMA of 865.8

Sharda Cropchem Ltd.

27 Jan 2025

824.10

-0.59%

Volume fuels revenue, continued price recovery uplifts outlook

Buy: Sharda Cropchem Ltd.

Recommendation Target

Khambatta Securities

? Sharda Cropchem Limited (SCL) reported solid growth in 3Q FY25 as revenues increased by 46.9% y-o-y to Rs 929.3 crore, fuelled by a robust increase in sales volume and a strategic price adjustment. Growth was observed across regions, with Europe and North America exhibiting
strong performance.
? Gross margin expanded by 650 bps y-o-y to 32.7%.

Number of FII/FPI investors decreased from 114 to 106 in Dec 2025 qtr

Sharda Cropchem Ltd.

27 Jan 2025

824.10

-0.59%

Decent show in Q3, growth momentum to continue; upgrading to a Buy

Buy: Sharda Cropchem Ltd.

Target

Anand Rathi

A gradual price increase, volume growth across regions and a good product mix drove Sharda Cropchem’s better-than-expected Q3 results. Growth would improve ahead as de-stocking is now complete

Number of FII/FPI investors decreased from 114 to 106 in Dec 2025 qtr

Is Sharda Cropchem Ltd. worth buying?

178 Votes:

Buy 80.34%

Sell 11.8%

Hold 7.87%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf